{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "10544035", "DateCompleted": {"Year": "1999", "Month": "12", "Day": "22"}, "DateRevised": {"Year": "2007", "Month": "11", "Day": "15"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0006-291X", "JournalIssue": {"Volume": "264", "Issue": "3", "PubDate": {"Year": "1999", "Month": "Nov", "Day": "02"}}, "Title": "Biochemical and biophysical research communications", "ISOAbbreviation": "Biochem Biophys Res Commun"}, "ArticleTitle": "Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.", "Pagination": {"StartPage": "944", "EndPage": "948", "MedlinePgn": "944-8"}, "Abstract": {"AbstractText": ["Recombinant mistletoe lectin (rML) belongs to the class of type II ribosome-inactivating proteins (RIP) composed of a catalytically active A-chain with rRNA N-glycosidase activity and a B-chain with carbohydrate binding properties. To investigate the contribution of the enzymatic activity of the rML A-chain to the observed cytotoxic and apoptotic effects, an rMLA E166Q R169Q molecule was developed by means of site-specific mutagenesis. Following heterologous expression, the activity of mutant rMLA was measured in a cell-free assay for rRNA-N-glycosidase activity. Moreover, after generation of heterodimer, the activities of mutant rML E166Q R169Q and rML wild type were determined in a cytotoxicity and apoptosis assay. Although the reduction of activity as measured in the cell-free RIP assay was more pronounced (factor 237) than in both cellular assays (factors 20-22), the data clearly indicate a close correlation between cytotoxicity, apoptosis, and the enzymatic activity of the rML A-chain. Thus, RIP activity is an essential feature of rML and therefore a prerequisite for its biological function as an anticancer agent."], "CopyrightInformation": "Copyright 1999 Academic Press."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "BRAIN GmbH, Zwingenberg, 64673, Germany. ml@brain-biotech.de"}], "LastName": "Langer", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "M\u00f6ckel", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Eck", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zinke", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lentzen", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochem Biophys Res Commun", "NlmUniqueID": "0372516", "ISSNLinking": "0006-291X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Lectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Synthesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Recombinant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ribonucleosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Ribosome Inactivating Proteins, Type 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Toxins, Biological"}, {"RegistryNumber": "0", "NameOfSubstance": "ribosome inactivating protein, Viscum"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Lectins"}, {"QualifierName": [], "DescriptorName": "Mistletoe"}, {"QualifierName": [], "DescriptorName": "Mutagenesis, Site-Directed"}, {"QualifierName": [], "DescriptorName": "Plant Lectins"}, {"QualifierName": [], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plant Proteins"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Synthesis Inhibitors"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Recombinant Proteins"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Ribonucleosides"}, {"QualifierName": [], "DescriptorName": "Ribosome Inactivating Proteins, Type 2"}, {"QualifierName": [], "DescriptorName": "Ribosomes"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Toxins, Biological"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "11", "Day": "2"}, {"Year": "1999", "Month": "11", "Day": "2", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "11", "Day": "2", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10544035", "10.1006/bbrc.1999.1610", "S0006-291X(99)91610-8"]}}]}